# Dolby Laboratories, Inc.: filings

DLB · NYSE · CIK 1308547 · [Financials](/sectors/financials.md) · fiscal year ends Sep 27

Pages: [Overview](/companies/dlb.md) · [Financials](/companies/dlb/financials.md) · [Filings](/companies/dlb/filings.md) · [Insiders](/companies/dlb/insiders.md)

## Reports and events: 291 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 1263, 8-K 142, 144 70, SC 13G/A 60, 10-Q 54, SC 13D/A 53, 3 29, 4/A 24, UPLOAD 19, 10-K 17, DEF 14A 17, DEFA14A 16, CORRESP 13, SD 13, SC 13G 11, ARS 10, S-8 7, 40-APP/A 3, 8-K/A 3, PRE 14A 3, SC TO-I/A 3, 10-K/A 2, 3/A 2, SCHEDULE 13D/A 2, SCHEDULE 13G 2, SCHEDULE 13G/A 2, SC TO-C 2, APP NTC 1, APP ORDR 1, SC 13D 1, SC TO-I 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-27 | 09:00 ET | [8-K](/filings/0001193125-26-369707.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-369707 |
| 2026-07-30 | 16:37 ET | [10-Q](/filings/0001308547-26-000013.md) | Quarterly report, period 2026-06-26 | 0001308547-26-000013 |
| 2026-07-30 | 16:15 ET | [8-K](/filings/0001193125-26-326149.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-326149 |
| 2026-04-30 | 16:45 ET | [10-Q](/filings/0001308547-26-000010.md) | Quarterly report, period 2026-03-27 | 0001308547-26-000010 |
| 2026-04-30 | 16:15 ET | [8-K](/filings/0001193125-26-197338.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-197338 |
| 2026-02-13 | 17:33 ET | [SCHEDULE 13D/A](/filings/0001193125-26-051828.md) | Ownership report, active investor, amended | 0001193125-26-051828 |
| 2026-02-06 | 16:15 ET | [8-K](/filings/0001193125-26-041211.md) | 5.07 Shareholder vote results | 0001193125-26-041211 |
| 2026-01-29 | 16:57 ET | [10-Q](/filings/0001308547-26-000005.md) | Quarterly report, period 2025-12-26 | 0001308547-26-000005 |
| 2026-01-29 | 16:15 ET | [8-K](/filings/0001193125-26-029373.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-029373 |
| 2025-12-16 | 08:30 ET | [DEF 14A](/filings/0001193125-25-320032.md) | Proxy statement, period 2026-02-03 | 0001193125-25-320032 |
| 2025-11-18 | 17:01 ET | [10-K](/filings/0001308547-25-000007.md) | Annual report, period 2025-09-26 | 0001308547-25-000007 |
| 2025-11-18 | 16:15 ET | [8-K](/filings/0001193125-25-286178.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-286178 |
| 2025-11-14 | 16:30 ET | [8-K](/filings/0001193125-25-283128.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-283128 |
| 2025-07-31 | 16:58 ET | [10-Q](/filings/0001628280-25-037059.md) | Quarterly report, period 2025-06-27 | 0001628280-25-037059 |
| 2025-07-31 | 16:15 ET | [8-K](/filings/0001193125-25-170537.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-170537 |
| 2025-05-01 | 16:52 ET | [10-Q](/filings/0001628280-25-021591.md) | Quarterly report, period 2025-03-28 | 0001628280-25-021591 |
| 2025-05-01 | 16:15 ET | [8-K](/filings/0001193125-25-109982.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-109982 |
| 2025-02-07 | 16:15 ET | [8-K](/filings/0001193125-25-022734.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-25-022734 |
| 2025-02-03 | 16:30 ET | [SCHEDULE 13D/A](/filings/0000950170-25-012351.md) | Ownership report, active investor, amended | 0000950170-25-012351 |
| 2025-01-30 | 16:06 ET | [10-Q](/filings/0001628280-25-003175.md) | Quarterly report, period 2024-12-27 | 0001628280-25-003175 |
| 2025-01-29 | 16:19 ET | [8-K](/filings/0001193125-25-015678.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-015678 |
| 2024-12-20 | 08:46 ET | [DEF 14A](/filings/0001193125-24-282542.md) | Proxy statement, period 2025-02-04 | 0001193125-24-282542 |
| 2024-11-19 | 17:07 ET | [10-K](/filings/0001628280-24-048519.md) | Annual report, period 2024-09-27 | 0001628280-24-048519 |
| 2024-11-19 | 16:19 ET | [8-K](/filings/0001193125-24-261743.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-261743 |
| 2024-11-15 | 16:30 ET | [8-K](/filings/0001193125-24-259854.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-259854 |
| 2024-08-19 | 17:00 ET | [8-K](/filings/0001193125-24-202859.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-202859 |
| 2024-08-07 | 17:11 ET | [10-Q](/filings/0001628280-24-035707.md) | Quarterly report, period 2024-06-28 | 0001628280-24-035707 |
| 2024-08-07 | 16:16 ET | [8-K](/filings/0001193125-24-195903.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-195903 |
| 2024-06-06 | 08:32 ET | [8-K](/filings/0001193125-24-155603.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-155603 |
| 2024-05-02 | 17:02 ET | [10-Q](/filings/0001628280-24-020061.md) | Quarterly report, period 2024-03-29 | 0001628280-24-020061 |
| 2024-05-02 | 16:16 ET | [8-K](/filings/0001193125-24-129380.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-129380 |
| 2024-02-09 | 16:19 ET | [8-K](/filings/0001193125-24-030031.md) | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-030031 |
| 2024-02-02 | 17:48 ET | [10-Q](/filings/0001628280-24-002964.md) | Quarterly report, period 2023-12-29 | 0001628280-24-002964 |
| 2024-02-01 | 16:15 ET | [8-K](/filings/0001193125-24-021860.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-021860 |
| 2023-12-22 | 08:35 ET | [DEF 14A](/filings/0001193125-23-301817.md) | Proxy statement, period 2024-02-06 | 0001193125-23-301817 |
| 2023-11-17 | 21:33 ET | [10-K](/filings/0001628280-23-039389.md) | Annual report, period 2023-09-29 | 0001628280-23-039389 |
| 2023-11-16 | 16:17 ET | [8-K](/filings/0001193125-23-278816.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-278816 |
| 2023-08-03 | 17:26 ET | [10-Q](/filings/0001628280-23-027347.md) | Quarterly report, period 2023-06-30 | 0001628280-23-027347 |
| 2023-08-03 | 16:16 ET | [8-K](/filings/0001171843-23-004979.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-23-004979 |
| 2023-05-05 | 18:00 ET | [10-Q](/filings/0001628280-23-015875.md) | Quarterly report, period 2023-03-31 | 0001628280-23-015875 |
| 2023-05-04 | 16:15 ET | [8-K](/filings/0001171843-23-002894.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-23-002894 |
| 2023-02-10 | 16:18 ET | [8-K](/filings/0001193125-23-032624.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-23-032624 |
| 2023-02-02 | 17:01 ET | [10-Q](/filings/0001628280-23-002065.md) | Quarterly report, period 2022-12-30 | 0001628280-23-002065 |
| 2023-02-02 | 16:15 ET | [8-K](/filings/0001171843-23-000636.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-23-000636 |
| 2022-12-19 | 08:30 ET | [DEF 14A](/filings/0001193125-22-307928.md) | Proxy statement, period 2023-02-07 | 0001193125-22-307928 |
| 2022-11-18 | 16:46 ET | [8-K](/filings/0001193125-22-289071.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-22-289071 |
| 2022-11-18 | 16:07 ET | [SC 13D/A](/filings/0001193125-22-288960.md) | Ownership report, active investor, amended | 0001193125-22-288960 |
| 2022-11-18 | 21:31 ET | [10-K](/filings/0001628280-22-030390.md) | Annual report, period 2022-09-30 | 0001628280-22-030390 |
| 2022-11-17 | 16:15 ET | [8-K](/filings/0001171843-22-007571.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-22-007571 |
| 2022-08-09 | 16:37 ET | [10-Q](/filings/0001628280-22-021971.md) | Quarterly report, period 2022-07-01 | 0001628280-22-021971 |

Page 1 of 6. [Older](/companies/dlb/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 09:52 ET. No prices; not investment advice.